Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Kamranta
3
Dec 07, 2007 06:20AM

Since the money goes though a third party, I have been wondering of the third party has been sitting on completed deals (and the money) so that the PRs could be release strategically.  Being a third party and a private company, they wouldn'thave the same reporting requirements with regard to this activity.

 I think this would be a smart way to handle things.  The company buying the license is not going to be public about their purchase.

 

 

Share
New Message
Please login to post a reply